128 related articles for article (PubMed ID: 21268272)
21. Epilysin (MMP-28) induces TGF-beta mediated epithelial to mesenchymal transition in lung carcinoma cells.
Illman SA; Lehti K; Keski-Oja J; Lohi J
J Cell Sci; 2006 Sep; 119(Pt 18):3856-65. PubMed ID: 16940349
[TBL] [Abstract][Full Text] [Related]
22. Proteomic analysis of secreted proteins of non-small cell lung cancer.
Huang LJ; Chen SX; Luo WJ; Jiang HH; Zhang PF; Yi H
Ai Zheng; 2006 Nov; 25(11):1361-7. PubMed ID: 17094902
[TBL] [Abstract][Full Text] [Related]
23. Ferritin heavy chain-mediated iron homeostasis and subsequent increased reactive oxygen species production are essential for epithelial-mesenchymal transition.
Zhang KH; Tian HY; Gao X; Lei WW; Hu Y; Wang DM; Pan XC; Yu ML; Xu GJ; Zhao FK; Song JG
Cancer Res; 2009 Jul; 69(13):5340-8. PubMed ID: 19531652
[TBL] [Abstract][Full Text] [Related]
24. Differential analysis of two-dimension gel electrophoresis profiles from the normal-metaplasia-dysplasia-carcinoma tissue of human bronchial epithelium.
Wu X; Xiao Z; Chen Z; Li C; Li J; Feng X; Yi H; Liang S; Chen P
Pathol Int; 2004 Oct; 54(10):765-73. PubMed ID: 15482566
[TBL] [Abstract][Full Text] [Related]
25. Human EAG1 potassium channels in the epithelial-to-mesenchymal transition in lung cancer cells.
Restrepo-Angulo I; Sánchez-Torres C; Camacho J
Anticancer Res; 2011 Apr; 31(4):1265-70. PubMed ID: 21508374
[TBL] [Abstract][Full Text] [Related]
26. [Mechanism study of antisense cyclin B1 in tumorigenesis inhibition using proteomic technique].
Yang T; Zhang L; Yan F; Tong AP; Liu XY; Liu HY; Huang CH
Ai Zheng; 2007 Mar; 26(3):264-9. PubMed ID: 17355788
[TBL] [Abstract][Full Text] [Related]
27. Proteomic analysis of the E2F1 response in p53-negative cancer cells: new aspects in the regulation of cell survival and death.
Li Z; Kreutzer M; Mikkat S; Mise N; Glocker MO; Pützer BM
Proteomics; 2006 Nov; 6(21):5735-45. PubMed ID: 17001603
[TBL] [Abstract][Full Text] [Related]
28. [Comparative proteome analysis of laser capture microdissection for purified primary tumor and lymph node metastatic tumor in human lung squamous carcinoma].
Deng G; Li D; Xiao Z; Li C; Yao H; Peng F; Li M; Zhang P; Chen Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Dec; 34(12):1182-8. PubMed ID: 20045912
[TBL] [Abstract][Full Text] [Related]
29. Cooperative signaling between oncostatin M, hepatocyte growth factor and transforming growth factor-β enhances epithelial to mesenchymal transition in lung and pancreatic tumor models.
Argast GM; Mercado P; Mulford IJ; O'Connor M; Keane DM; Shaaban S; Epstein DM; Pachter JA; Kan JL
Cells Tissues Organs; 2011; 193(1-2):114-32. PubMed ID: 21041998
[TBL] [Abstract][Full Text] [Related]
30. Differential expression proteomics of human colon cancer.
Mazzanti R; Solazzo M; Fantappié O; Elfering S; Pantaleo P; Bechi P; Cianchi F; Ettl A; Giulivi C
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1329-38. PubMed ID: 16439467
[TBL] [Abstract][Full Text] [Related]
31. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells.
Willipinski-Stapelfeldt B; Riethdorf S; Assmann V; Woelfle U; Rau T; Sauter G; Heukeshoven J; Pantel K
Clin Cancer Res; 2005 Nov; 11(22):8006-14. PubMed ID: 16299229
[TBL] [Abstract][Full Text] [Related]
32. A Proteomic approach for protein-profiling the oncogenic ras induced transformation (H-, K-, and N-Ras) in NIH/3T3 mouse embryonic fibroblasts.
Kim S; Lee YZ; Kim YS; Bahk YY
Proteomics; 2008 Aug; 8(15):3082-93. PubMed ID: 18601226
[TBL] [Abstract][Full Text] [Related]
33. Cell characterization by proteome profiling applied to primary hepatocytes and hepatocyte cell lines Hep-G2 and Hep-3B.
Slany A; Haudek VJ; Zwickl H; Gundacker NC; Grusch M; Weiss TS; Seir K; Rodgarkia-Dara C; Hellerbrand C; Gerner C
J Proteome Res; 2010 Jan; 9(1):6-21. PubMed ID: 19678649
[TBL] [Abstract][Full Text] [Related]
34. [The influence of temperature on the protein expression of human lung cancer cell line A549].
Chen ZJ; Wang SY; Chen JA; Peng XX
Shi Yan Sheng Wu Xue Bao; 2002 Sep; 35(3):179-83. PubMed ID: 15344378
[TBL] [Abstract][Full Text] [Related]
35. Proteomics-based identification of tumor relevant proteins in lung adenocarcinoma.
Zhou X; Xue L; Hao L; Liu S; Zhou F; Xiong H; Qi X; Lin D; Shao S
Biomed Pharmacother; 2013 Sep; 67(7):621-7. PubMed ID: 23916545
[TBL] [Abstract][Full Text] [Related]
36. Approaches to proteomic analysis of human tumors.
Ahram M; Emmert-Buck MR
Methods Mol Biol; 2003; 222():375-84. PubMed ID: 12710699
[TBL] [Abstract][Full Text] [Related]
37. Proteomic profiling of human pleural effusion using two-dimensional nano liquid chromatography tandem mass spectrometry.
Tyan YC; Wu HY; Lai WW; Su WC; Liao PC
J Proteome Res; 2005; 4(4):1274-86. PubMed ID: 16083277
[TBL] [Abstract][Full Text] [Related]
38. Identificating 14-3-3 sigma as a lymph node metastasis-related protein in human lung squamous carcinoma.
Li DJ; Deng G; Xiao ZQ; Yao HX; Li C; Peng F; Li MY; Zhang PF; Chen YH; Chen ZC
Cancer Lett; 2009 Jun; 279(1):65-73. PubMed ID: 19231067
[TBL] [Abstract][Full Text] [Related]
39. Comparative proteomic analysis of lung cancer cell line and lung fibroblast cell line.
Rubporn A; Srisomsap C; Subhasitanont P; Chokchaichamnankit D; Chiablaem K; Svasti J; Sangvanich P
Cancer Genomics Proteomics; 2009; 6(4):229-37. PubMed ID: 19657000
[TBL] [Abstract][Full Text] [Related]
40. Application of saturation labeling in lung cancer proteomics.
Poschmann G; Sitek B; Sipos B; Stühler K
Methods Mol Biol; 2012; 854():253-67. PubMed ID: 22311766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
